Evidence-Based Medicine Guidelines
Brivaracetam add‐on therapy for drug‐resistant epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Brivaracetam Add‐on Therapy for Drug‐resistant Epilepsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305292/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy.
Brivaracetam add‐on therapy for drug‐resistant epilepsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305292/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy. Accessed November 22, 2024.
Brivaracetam add‐on therapy for drug‐resistant epilepsy. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305292/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy
Brivaracetam Add‐on Therapy for Drug‐resistant Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305292/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Brivaracetam add‐on therapy for drug‐resistant epilepsy
ID - 1305292
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305292/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
